Roy MD - SomaLogic CEO Director

Insider

Roy MD is CEO Director of SomaLogic
Age 62
Phone303 625 9000
Webhttps://www.somalogic.com

SomaLogic Management Efficiency

The company has return on total asset (ROA) of (0.1417) % which means that it has lost $0.1417 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2372) %, meaning that it generated substantial loss on money invested by shareholders. SomaLogic's management efficiency ratios could be used to measure how well SomaLogic manages its routine affairs as well as how well it operates its assets and liabilities.
SomaLogic has accumulated 2.48 M in total debt with debt to equity ratio (D/E) of 0.01, which may suggest the company is not taking enough advantage from borrowing. SomaLogic has a current ratio of 18.48, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Note, when we think about SomaLogic's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 7 records

INSIDER Age

Michael McKennaQuantum Si incorporated
62
Claudia DraytonQuantum Si incorporated
56
Todd RearickQuantum Si incorporated
N/A
John StarkQuantum Si incorporated
50
Christian LapointeQuantum Si incorporated
53
Michael MDQuantum Si incorporated
40
Matthew DyerQuantum Si incorporated
43
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. The company was incorporated in 1999 and is headquartered in Boulder, Colorado. Somalogic Inc operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 320 people. SomaLogic (SLGCW) is traded on NASDAQ Exchange in USA and employs 451 people.

Management Performance

SomaLogic Leadership Team

Elected by the shareholders, the SomaLogic's board of directors comprises two types of representatives: SomaLogic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SomaLogic. The board's role is to monitor SomaLogic's management team and ensure that shareholders' interests are well served. SomaLogic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SomaLogic's outside directors are responsible for providing unbiased perspectives on the board's policies.
Adam Taich, Exec Unit
Ruben JD, G Counsel
Alison Roelke, VP Culture
Jason Cleveland, Chief Officer
Shaun Blakeman, Chief Officer
Nebojsa Janjic, Chief Officer
Roy MD, CEO Director
Todd Johnson, Exec Unit
BS MB, Chief Officer
Troy MBA, Ex Chairman

SomaLogic Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is SomaLogic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Consideration for investing in SomaLogic Stock

If you are still planning to invest in SomaLogic check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SomaLogic's history and understand the potential risks before investing.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Fundamental Analysis
View fundamental data based on most recent published financial statements
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges